Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

Diabetes

Volumn 49, Issue 5, 2000, Pages 749-758

  Ryysy, Leena ^a   Häkkinen, Anna Maija ^a   Goto, Takashi ^a   Vehkavaara, Satu ^a   Westerbacka, Jukka ^a   Halavaara, Juha ^a   Yki Järvinen, Hannele ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; DIABETES MELLITUS; FATTY ACID METABOLISM; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0342314436     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.5.749     Document Type: Article

References (42)

1. Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P. Tulokas T, Viikari J, Karjalainen J, Taskinen M-R: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327:1426-1433, 1992
2. Riddle MC, Schneider J: Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone: Glimepiride Combination Group. Diabetes Care 21:1052-1057, 1998
3. Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M: Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 130:389-396, 1999
4. 125I-NPII insulin in diabetic patients. Horm Metab Res 15:274-278, 1983
5. Hildebrandt P, Birch K, Sestoft L, Volund A: Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins. Acta Med Scand 215:69-73, 1984
6. Vora JP, Burch A, Peters JR, Owens DR: Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry. Diabet Med 10:736-743, 1993
7. de Meijer PH, Lutterman JA, van Lier HJ, van't Laar A: The variability of the absorption of subcutaneously injected insulin: effect of injection technique and relation with brittleness. Diabet Med 7:499-505, 1990
8. Frid A, Linde B: Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 9:236-239, 1992
9. Lauritzen T, Pramming S. Gale EA, Deckert T, Binder C: Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed) 285:159-162, 1982
10. Hildebrandt P: Subcutaneous absorption of insulin in insulin-dependent diabetic patients: influence of species, physico-chemical properties of insulin and physiological factors. Dan Med Bull 38:337-346, 1991
11. Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E: Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 37:377-380, 1994
12. Vora JP, Burch A, Peters JR, Owens DR: Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15:1484-1493, 1992
13. Hildebrandt P: Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. Acta Physiol Scand Suppl 603:41-45, 1991
14. Ziel FH, Davidson MB, Harris MD, Rosenberg CS: The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med 5:662-666, 1988
15. Clauson PG, Linde B: Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care 18:986-991, 1995
16. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE: Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757, 1997
17. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
18. Puhakainen I, Koivisto VA, Yki-Järvinen H: No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40:1319-1327, 1991
19. Yki-Järvinen H, Koivisto VA, Karonen S-L: Influence of body composition on insulin clearance. Clin Physiol 5:45-52, 1985
20. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT: Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276:E977-E989, 1999
21. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O: Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495, 1994
22. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28:297-302, 1993
23. Yki-Järvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen M-R: Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689, 1991
24. Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
25. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 33:732-738, 1971
26. Miles J, Classcock R, Aikens J, Gerich J, Haymond N: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99, 1983
27. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
28. Gidez LJ, Miller GJ, Burstein M, Eder HA: Analysis of plasma high density lipoprotein subclasses by a precipitation procedure: correlation with preparative and analytical ultracentrifugation. In High Density Lipoprotein Methodology Workshop, San Francisco, 1979. Lippel K, Ed. Bethesda MD, Department of Health, Education, and Welfare, 1970, p. 328-342 (NIH publ. no. 79-1661)
29. Stenman U-H, Pesonen K, Ylinen K, Huhtala ML, Teramo K: Rapid Chromatographic quantitation of glycosylated haemoglobins. J Chromatogr 297:327-332, 1984
30. Gerbitz KD, Kemmler W: Method for rapid quantitation and characterization of insulin antibodies. Clin Chem 24:890-894, 1978
31. Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L: Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 21:800-803, 1998
32. Yki-Järvinen H, Young AA, Lamkin C, Foley JE: Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79:1713-1719, 1987
33. Yki-Järvinen H, Bogardus C, Howard BV: Hyperglycemia stimulates carbohydrate oxidation in man. Am J Physiol 253:E376-E382, 1987
34. Taskinen M-R, Sane T, Helve E, Karonen S-L, Nikkilä EA, Yki-Järvinen H: Bedtime insulin for suppression of overnight free fatty acid, blood glucose, and glucose production in NIDDM. Diabetes 38:580-588, 1989
35. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangbuni T, Reilly T, Gerich J: Contribution of abnormal muscle and liver metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
36. Yki-Järvinen H: Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38:1378-1388, 1995
37. Yki-Järvinen H: The liver as a target for therapy in non-insulin-dependent diabetes mellitus. Diab Nutr Metab 7:109-119, 1994
38. James O, Day C: Non-alcoholic steatohepatitis: another disease of affluence. Lancet 353:1634-1636, 1999
39. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513-1517, 1999
40. Arner P: Not all fat is alike. Lancet 351:1301-1302, 1998
41. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WGH, Zawadzki JK, Yki-Järvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415-424, 1987
42. Malmström R, Packard CJ, Watson TDG, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen M-R: Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1464, 1997